JPH0446589B2 - - Google Patents

Info

Publication number
JPH0446589B2
JPH0446589B2 JP60086555A JP8655585A JPH0446589B2 JP H0446589 B2 JPH0446589 B2 JP H0446589B2 JP 60086555 A JP60086555 A JP 60086555A JP 8655585 A JP8655585 A JP 8655585A JP H0446589 B2 JPH0446589 B2 JP H0446589B2
Authority
JP
Japan
Prior art keywords
body fluid
casing
hollow fiber
fluid treatment
sterilization
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP60086555A
Other languages
Japanese (ja)
Other versions
JPS61244372A (en
Inventor
Koji So
Hidetaka Azuma
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SB Kawasumi Laboratories Inc
Original Assignee
Kawasumi Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kawasumi Laboratories Inc filed Critical Kawasumi Laboratories Inc
Priority to JP60086555A priority Critical patent/JPS61244372A/en
Publication of JPS61244372A publication Critical patent/JPS61244372A/en
Publication of JPH0446589B2 publication Critical patent/JPH0446589B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • External Artificial Organs (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)

Description

【発明の詳細な説明】[Detailed description of the invention]

(産業上の利用分野) 本発明は、人工腎臓、血漿分離処理装置その他
の体液処理装置の滅菌方法に関するものである。 (従来技術及びその問題点) 人工腎臓、血漿分離処理装置、人工肺、人工肝
臓等の体液処理装置は、ケーシングの中に多数の
中空糸膜を収納し、その中空糸膜の両端部をウレ
タン等の固定部材で固定した構造となつている。 従来、このような体液処理装置を滅菌するにあ
たつては、乾燥状態の中空糸膜をケーシング内に
組み込み、体液出入口やケーシングの透析液等の
出入口を開放した状態で直接高圧蒸気滅菌を行つ
ていた。しかし、水は蒸発熱が高いので水蒸気に
より膜が急激な熱をうけ、吸湿し、滅菌後の乾燥
過程における糸の収縮及び支持部材の陥没、クラ
ツク等が生成し、膜機能が著しく低下するととも
に、体液処理装置自体が破損することもあつた。 このため、たとえば特開昭53−84394号や同53
−84395号で提案されているごとく、中空糸膜を
収納したケーシング内に生体に無害な生理食塩
水、蒸留水等を充填し、開口部を密栓した後、高
圧蒸気滅菌する方法も知られている。この方法に
よると、膜機能低下の面ではある程度解決された
が、滅菌時、充填液の膨張による破損が問題とな
るため、これを逃すための緩衝部材(膨張性の
栓、液入りバツグ等)が必要となり、製造工程の
能率が低下し、コストアツプの原因となつてい
た。 本発明は、このような従来技術の問題点を解決
するために提案されたものである。 (問題点を解決するための手段) 本発明はケーシング内に中空糸膜や吸着剤等の
体液処理部材が収容された装置を滅菌するにあた
り、前記体液処理部材を、濃度70v/v%〜
95v/v%のエチルアルコール又はイソプロルア
ルコールでウエツト化すると共に、該ケーシング
内部を減圧状態に維持して高温加熱処理するもの
である。 本発明における体液処理装置とは、具体的には
人工腎臓、血漿分離処理装置、人工肺、人工肝臓
等である。またケーシング内に収容される体液処
理部材とは中空糸膜や吸着剤等であり、中空糸膜
としては、セルロース系、ポリビニルアルコール
系、ポリエステル系、ポリスルホン、ポリメチル
メタクリレート、ポリアクリロニトリル、等が使
用され、その素材の限定はない。 中空糸膜の場合、その束はケーシング内に収容
され、両端部がウレタン樹脂等の支持部材によつ
て固定されている。また一方の端部には体液導入
口が設けられ、他方の端部には体液導出口が設け
られるとともに、前記ケーシングには、たとえば
透析液の出入口や排液の出口等が設けられてい
る。 本発明においてエチルアルコール又はイソプロ
ピルアルコールの濃度を70v/v%〜95v/v%
に限定する理由は、これらのアルコールは低沸点
であるため、95v/v%以上のアルコール分のみ
では低温で蒸発してしまい、十分に滅菌できず、
また70v/v%以下では蒸発熱が水の影響より大
きくなるため膜が劣化しやすいためである。した
がつて、膜機能低下がなく滅菌が充分可能な
70v/v%〜95v/v%の範囲が好ましい。 前記低蒸発熱有機物の水溶液で体液処理部材を
ウエツト化するためには、通常、その水溶液を体
液導入口から中空糸膜等の体液処理部材内に注入
する。その注入量は体液処理部材を湿潤させる程
度の量、たとえば5〜100mlとする。その注入方
法は、中空糸膜の外側すなわちケーシング内に注
入してもよく、ハウジング、中空糸、ウレタン
(膜の固定部)全体にゆきわたる方法であれば良
い。 また本発明では、ケーシング内部に存在する空
気及び体液処理部材内に存在する空気を体液導入
口とケーシング開口部から真空吸引し、内部をた
とえば30mmHg以下の減圧状態に維持しておく。
これにより、高圧蒸気滅菌時の空気の熱膨張を防
いでいる。 なお、前記体液導入口やケーシングの開口部は
シリコーンゴム等の弾性ボールを組み込んだ栓で
封止されており、前記水溶液の注入や、真空吸引
は、この栓にシリンジの針を刺し込んで行なうと
よい。 本発明により高圧蒸気滅菌をするに当つては、上
記濃度のエチルアルコール又はイソプロピルアル
コールの水溶液が注入され、内部が減圧された体
液処理装置を、通気部を有する包装容器(たとえ
ばポリプロピレン製)に封入し、通常100〜130℃
の高圧蒸気中で5〜30分間加熱処理をする。その
後、室温にもどし、袋ごしに栓を開けて体液処理
装置内部を常圧にもどした後、体液処理装置の内
部と中空糸膜に残存しているエチルアルコール又
はイソプロピルアルコールの水溶液を真空乾燥し
て除去させるものである。 (実施例) 第1図に示すごとく、中空糸型人工腎臓(セル
ロース系中空糸膜)の血液導入口1、血液導出口
2、透析液入口3、透析液出口4をそれぞれ第2
図に示すようなシリコーンゴム製ボール5を組み
込んだ栓6で密封した。その後、血液導入口1か
らシリンジにより70%、80%、90%のエチルアル
コール水溶液を中空糸膜内部へ注入し、その中空
糸膜を湿潤状態にした。 なお、エチルアルコールは蒸発熱が200cal/g
(水は540cal/g)である。 次に、血液導入口1と透析液入口3に真空ポン
プと接続した針7,7を穿入し、中空糸側とケー
シング側の両方から真空吸引することにより、人
工腎臓の内部を30mmHg程度の減圧状態に維持し
た。その後、前記人工腎臓を、下記第1表〜第3
表の条件の高圧蒸気中で加熱処理した。それぞれ
のエチルアルコール濃度における生存菌を測定
し、生存曲線を作成しD値(Decimal reduction
value)を求めた。これを第3図〜第5図に示す。 なお、第3図は第1表、第4図は第2表、第5
図は第3表に対応するものである。 同実施例に示すごとく、エチルアルコール水溶
液でウエツト化した状態で高温加熱滅菌をすれ
ば、低温域でも充分な滅菌効果が得られることが
わかる。また本実施例では、エチルアルコール濃
度が70%になると、やや膜の性能低下がみられた
が、実用には支障はなく、膜性能も満足のいくレ
ベルに維持できた。さらにケーシングにもクラツ
ク等の発生はみられなかつた。 (効果) 以上の実施例にみられるように、本発明によれ
ば、体液処理装置を高温加熱滅菌するに際し、支
持部材に固定された中空糸膜等の性能を低下させ
ることなく、アルコール濃度によつては従来の高
圧蒸気滅菌より短時間で、かつ低温にて滅菌する
ことができる。また低温域で滅菌することができ
るため、従来のごとく、ケーシングの口部等に内
部充填液の圧力逃げ用の緩衝部材を設ける必要が
なくなるため、製造工程の省力化、コストダウン
が可能となる等のすぐれた効果が得られることに
なる。
(Industrial Application Field) The present invention relates to a method for sterilizing artificial kidneys, plasma separation processing devices, and other body fluid processing devices. (Prior art and its problems) Body fluid processing devices such as artificial kidneys, plasma separation processing devices, artificial lungs, and artificial livers house a large number of hollow fiber membranes in a casing, and both ends of the hollow fiber membranes are covered with urethane. It has a structure in which it is fixed with fixing members such as. Conventionally, when sterilizing such body fluid processing equipment, a dry hollow fiber membrane was built into the casing, and the body fluid inlet/outlet and the dialysate inlet/outlet of the casing were left open and high-pressure steam sterilization was performed directly. It was on. However, since water has a high heat of evaporation, the membrane receives rapid heat from the water vapor and absorbs moisture, resulting in shrinkage of the threads during the drying process after sterilization, caving in of the supporting member, cracks, etc., and a significant decline in membrane function. In some cases, the body fluid treatment equipment itself was damaged. For this reason, for example, JP-A No. 53-84394 and JP-A No. 53-84394,
There is also a known method, as proposed in No. 84395, of filling a casing containing a hollow fiber membrane with physiological saline, distilled water, etc. that is harmless to living organisms, sealing the opening, and then sterilizing it with high-pressure steam. There is. This method has solved the problem of reduced membrane function to some extent, but the problem is that the filling liquid expands and breaks during sterilization, so a buffer member (expandable stopper, liquid-filled bag, etc.) is used to release the liquid. This required a reduction in the efficiency of the manufacturing process and caused an increase in costs. The present invention was proposed to solve the problems of the prior art. (Means for Solving the Problems) When the present invention sterilizes an apparatus in which a body fluid treatment member such as a hollow fiber membrane or an adsorbent is housed in a casing, the body fluid treatment member is sterilized at a concentration of 70v/v% to
The casing is wetted with 95 v/v % ethyl alcohol or isopropyl alcohol, and the inside of the casing is kept under reduced pressure and subjected to high temperature heat treatment. Specifically, the body fluid processing device in the present invention includes an artificial kidney, a plasma separation processing device, an artificial lung, an artificial liver, and the like. The body fluid treatment members housed in the casing include hollow fiber membranes and adsorbents, and the hollow fiber membranes used include cellulose, polyvinyl alcohol, polyester, polysulfone, polymethyl methacrylate, and polyacrylonitrile. There are no restrictions on the material used. In the case of hollow fiber membranes, the bundle is housed in a casing, and both ends are fixed by support members such as urethane resin. Further, one end is provided with a body fluid inlet, and the other end is provided with a body fluid outlet, and the casing is provided with, for example, a dialysate inlet/outlet, a drainage outlet, and the like. In the present invention, the concentration of ethyl alcohol or isopropyl alcohol is 70v/v% to 95v/v%.
The reason for limiting this is that these alcohols have low boiling points, so if the alcohol content is 95v/v% or more, it will evaporate at low temperatures and cannot be sterilized sufficiently.
Further, if the amount is less than 70v/v%, the heat of evaporation becomes greater than the effect of water, and the film tends to deteriorate. Therefore, sterilization is possible without deterioration of membrane function.
A range of 70v/v% to 95v/v% is preferred. In order to wet the body fluid treatment member with the aqueous solution of the low heat of vaporization organic substance, the aqueous solution is usually injected into the body fluid treatment member such as a hollow fiber membrane through the body fluid inlet. The injection amount is set to be enough to wet the body fluid treatment member, for example, 5 to 100 ml. The injection method may be to inject into the outside of the hollow fiber membrane, that is, into the casing, or it may be a method that covers the entire housing, hollow fibers, and urethane (fixed part of the membrane). Further, in the present invention, the air present inside the casing and the air present within the body fluid treatment member are vacuum-suctioned from the body fluid inlet and the casing opening, and the interior is maintained at a reduced pressure of, for example, 30 mmHg or less.
This prevents thermal expansion of air during high-pressure steam sterilization. Note that the body fluid inlet and the opening of the casing are sealed with a plug incorporating an elastic ball such as silicone rubber, and injection of the aqueous solution and vacuum suction are performed by inserting a syringe needle into the plug. Good. In performing high-pressure steam sterilization according to the present invention, a body fluid treatment device into which an aqueous solution of ethyl alcohol or isopropyl alcohol of the above concentration is injected and whose interior is depressurized is enclosed in a packaging container (for example, made of polypropylene) having a vent. Usually 100~130℃
Heat treatment in high pressure steam for 5 to 30 minutes. After that, the temperature is returned to room temperature, the inside of the body fluid treatment device is returned to normal pressure by opening the stopper through the bag, and the aqueous solution of ethyl alcohol or isopropyl alcohol remaining inside the body fluid treatment device and the hollow fiber membrane is vacuum-dried. and remove it. (Example) As shown in Figure 1, the blood inlet 1, blood outlet 2, dialysate inlet 3, and dialysate outlet 4 of a hollow fiber artificial kidney (cellulose-based hollow fiber membrane) are connected to the second
It was sealed with a stopper 6 incorporating a silicone rubber ball 5 as shown in the figure. Thereafter, 70%, 80%, and 90% aqueous ethyl alcohol solutions were injected into the hollow fiber membrane using a syringe through the blood inlet 1 to moisten the hollow fiber membrane. Furthermore, the heat of vaporization of ethyl alcohol is 200 cal/g.
(Water is 540 cal/g). Next, needles 7, 7 connected to a vacuum pump are inserted into the blood inlet 1 and the dialysate inlet 3, and vacuum suction is applied from both the hollow fiber side and the casing side, so that the inside of the artificial kidney is heated to about 30 mmHg. A vacuum was maintained. Thereafter, the artificial kidney is
Heat treatment was performed in high pressure steam under the conditions shown in the table. The number of viable bacteria at each ethyl alcohol concentration was measured, a survival curve was created, and the D value (Decimal reduction
value). This is shown in FIGS. 3 to 5. Furthermore, Figure 3 is based on Table 1, Figure 4 is based on Table 2, and Figure 4 is based on Table 5.
The figure corresponds to Table 3. As shown in the same example, it can be seen that sufficient sterilization effect can be obtained even in a low temperature range by performing high temperature heat sterilization in a state wetted with an aqueous ethyl alcohol solution. Further, in this example, when the ethyl alcohol concentration reached 70%, a slight decrease in membrane performance was observed, but there was no problem in practical use, and the membrane performance was maintained at a satisfactory level. Furthermore, no cracks or the like were observed in the casing. (Effects) As seen in the above examples, according to the present invention, when sterilizing a body fluid treatment device by heating at high temperature, the alcohol concentration can be adjusted without reducing the performance of the hollow fiber membrane etc. fixed to the support member. As a result, sterilization can be performed in a shorter time and at lower temperatures than conventional high-pressure steam sterilization. In addition, since sterilization can be performed at low temperatures, there is no need to provide a buffer member at the mouth of the casing to relieve the pressure of the internal filling liquid, which makes it possible to save labor and reduce costs in the manufacturing process. Excellent effects such as these can be obtained.

【表】【table】

【表】【table】

【表】【table】 【図面の簡単な説明】[Brief explanation of drawings]

第1図は本発明の実施例を説明するための体液
処理装置の概略図、第2図は本発明における口部
の密封栓の構造を示す断面図、第3図〜第5図は
本発明の実施例における菌生存曲線である。 図中、1は血液導入口、2は血液導出口、3は
透析液入口、4は透析液出口、5は弾性ボール、
6は栓である。
FIG. 1 is a schematic diagram of a body fluid treatment device for explaining an embodiment of the present invention, FIG. 2 is a cross-sectional view showing the structure of the mouth sealing plug according to the present invention, and FIGS. 3 to 5 are according to the present invention. 1 is a bacterial survival curve in Example. In the figure, 1 is a blood inlet, 2 is a blood outlet, 3 is a dialysate inlet, 4 is a dialysate outlet, 5 is an elastic ball,
6 is a stopper.

Claims (1)

【特許請求の範囲】[Claims] 1 体液処理部材がケーシング内に収容された装
置を滅菌するにあたり、前記体液処理部材を、濃
度70v/v%〜95v/v%のエチルアルコール又
はイソプロルアルコールでウエツト化すると共
に、該ケーシング内部を減圧状態に維持して高温
加熱処理することを特徴とする体液処理装置の滅
菌方法。
1. When sterilizing a device in which a body fluid treatment member is housed in a casing, the body fluid treatment member is wetted with ethyl alcohol or isopropyl alcohol with a concentration of 70 v/v% to 95 v/v%, and the inside of the casing is A method for sterilizing a body fluid treatment device, characterized by performing high temperature heat treatment while maintaining the device in a reduced pressure state.
JP60086555A 1985-04-24 1985-04-24 Sterilization of body fluid treating apparatus Granted JPS61244372A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP60086555A JPS61244372A (en) 1985-04-24 1985-04-24 Sterilization of body fluid treating apparatus

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP60086555A JPS61244372A (en) 1985-04-24 1985-04-24 Sterilization of body fluid treating apparatus

Publications (2)

Publication Number Publication Date
JPS61244372A JPS61244372A (en) 1986-10-30
JPH0446589B2 true JPH0446589B2 (en) 1992-07-30

Family

ID=13890251

Family Applications (1)

Application Number Title Priority Date Filing Date
JP60086555A Granted JPS61244372A (en) 1985-04-24 1985-04-24 Sterilization of body fluid treating apparatus

Country Status (1)

Country Link
JP (1) JPS61244372A (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE510026C2 (en) * 1994-09-23 1999-04-12 Gambro Ab Disinfection device for dialysis machine
US5647984A (en) * 1995-06-07 1997-07-15 Cobe Laboratories, Inc. Extracorporeal fluid treatment systems selectively operable in a treatment mode or a disinfecting mode
JPH10235167A (en) * 1997-02-24 1998-09-08 Asahi Chem Ind Co Ltd Removing method for alcohol from porous membrane

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56104672A (en) * 1980-01-23 1981-08-20 Nikkiso Co Ltd Method of sterilizing blood purifier
JPS5749465A (en) * 1980-09-10 1982-03-23 Terumo Corp Artificial internal organ for thermal sterization
JPS57206452A (en) * 1981-06-11 1982-12-17 Kuraray Co Pasturization of body liquid treating apparatus

Also Published As

Publication number Publication date
JPS61244372A (en) 1986-10-30

Similar Documents

Publication Publication Date Title
US4411866A (en) Steam sterilization method for artificial organ assemblies and resultant sterilized product
TW200403087A (en) Wound therapy and tissue management system and method with fluid differentiation
EP0186642A2 (en) Fluid and particle absorbing body for apertures in injection instruments
JPH0446589B2 (en)
CN108042838A (en) A kind of preparation method of anti-oxidative nanofiber electrospinning film medical dressing
JPS5931345B2 (en) Method for producing artificial organs sterilized by high-pressure steam
JPH05192397A (en) Method for manufacturing blood purification device
JPS6012072A (en) Treatment of cellulose hollow fiber
US7125516B2 (en) Vacuum drying process used for manufacturing dialyzer
ES2342151T3 (en) USE OF A WATER GLICEROL SOLUTION TO PRESERVE THE FUNCTIONAL CHARACTERISTICS OF SEMIPERMEABLE WET MEMBRANES DESTINED TO THE TREATMENT OF BLOOD OR PLASMA.
JP2629084B2 (en) Preservation method of membrane oxygenator
JPS6213022B2 (en)
JP2779257B2 (en) Blood processing equipment sterilization method
JPS59105808A (en) Pasteurization of apparatus using permeable membrane
JPS6253656A (en) Method and apparatus for sterilizing medical instrument
JPS609818B2 (en) artificial organs
JPS5915644Y2 (en) Dialyzer disinfectant removal device
CN222445141U (en) Quick cleaning sterilizer for emergency treatment
CN223126979U (en) A negative pressure waterproof device for peritoneal dialysis catheter
RU2041718C1 (en) Method for sterilizing physiologic extracorporeal blood circulation devices
JPS606660B2 (en) Method for manufacturing sterile artificial organs
JPS5946612B2 (en) Manufacturing method for high-pressure steam sterilized artificial kidney
JPS6250150B2 (en)
JPH0288074A (en) Manufacture of blood treating device
JPS6251642B2 (en)

Legal Events

Date Code Title Description
LAPS Cancellation because of no payment of annual fees